Recombinant Human Factor VIII protein (GST tag N-Terminus)
Be the first to review this product! Submit a review
|
(1 Publication)
Recombinant Human Factor VIII protein (GST tag N-Terminus) is a Human Full Length protein, in the 1 to 216 aa range, expressed in Wheat germ, suitable for ELISA, WB.
View Alternative Names
F8C, F8, Coagulation factor VIII, Antihemophilic factor, Procoagulant component, AHF
- SDS-PAGE
Unknown
SDS-PAGE - Recombinant Human Factor VIII protein (GST tag N-Terminus) (AB158403)
ab158403 on a 12.5% SDS-PAGE stained with Coomassie Blue.
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Factor VIII greatly contributes to hemostasis by serving as a cofactor for factor IXa forming the intrinsic tenase complex. This activation results in the conversion of factor X to factor Xa which is important for the common pathway of the coagulation cascade. By participating in the clotting process factor VIII ensures proper wound healing and prevention of blood loss.
Pathways
Factor VIII activity is pivotal within the coagulation cascade particularly the intrinsic and common pathways. Activation of the intrinsic pathway begins through interactions with factor IXa leading to efficient activation of factor X. This process closely relates factor VIII to proteins like factor IX and factor X ensuring proper clot formation and stabilization. Factor VIII products and assays are available to study and characterize its critical role in these pathways.
Specifications
Form
Liquid
General info
Function
Factor VIII, along with calcium and phospholipid, acts as a cofactor for F9/factor IXa when it converts F10/factor X to the activated form, factor Xa.
Sequence similarities
Belongs to the multicopper oxidase family.
Post-translational modifications
Sulfation on Tyr-1699 is essential for binding vWF.. Proteolytically cleaved by cathepsin CTSG to produce a partially activated form.
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Mediterranean journal of hematology and infectious diseases 13:e2021041 PubMed34276910
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com